Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

MERCK & CO., INC.

(MRK)
  Report
Delayed Nyse  -  04:03 2022-09-27 pm EDT
85.84 USD   -0.39%
09/27Merck & Co.'s Keytruda Wins Four New Approvals in Japan for Cancer Indications
MT
09/27Merck Division Merck Animal Health Closes Minority Investment in LeeO Precision Farming
MT
09/27TILT Biotherapeutics Collaborates with MSD on Immunotherapy Clinical Trial in Checkpoint Inhibitor Refractory Non-Small Cell Lung Cancer
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about MERCK & CO., INC.
09/27Merck & Co.'s Keytruda Wins Four New Approvals in Japan for Cancer Indications
MT
09/27Merck Division Merck Animal Health Closes Minority Investment in LeeO Precision Farming
MT
09/27TILT Biotherapeutics Collaborates with MSD on Immunotherapy Clinical Trial in Checkpoin..
AQ
09/27Merck & Co. Unit Buys Minority Stake In LeeO Precision Farming
MT
09/27Merck Says Keytruda Obtains Four New Approvals in Japan
MT
09/27Merck Animal Health Completes Minority Investment in LeeO Precision Farming
BU
09/27Merck's KEYTRUDA« (pembrolizumab) Receives Four New Approvals in Japan, Including in Hi..
BU
09/26TILT Biotherapeutics Ltd Collaborates with Merck & Co., Inc on Immunotherapy Clinical T..
CI
09/23Merck - LYNPARZA Approved in China as First-Line Maintenance Treatment with Bevacizumab..
AQ
09/22Trending : Merck Reports Court Win in Diabetes Patent Lawsuit Against Viatris
DJ
09/22Merck Boosts Animal-Health Line With Virtual-Fence-Firm Vence
DJ
09/22Merck's Animal Health Unit to Acquire Vence From Founders and Shareholders
MT
09/22Merck Animal Health to Acquire Vence
BU
09/22Merck Says it Received Favorable Court Ruling in Patent Lawsuit Against Viatris
MT
09/22LYNPARZA« (olaparib) Approved in China as First-Line Maintenance Treatment With Bevaciz..
BU
More most relevant news
All news about MERCK & CO., INC.
09/27Merck & Co.'s Keytruda Wins Four New Approvals in Japan for Cancer Indications
MT
09/27Merck Division Merck Animal Health Closes Minority Investment in LeeO Precision Farming
MT
09/27TILT Biotherapeutics Collaborates with MSD on Immunotherapy Clinical Trial in Checkpoin..
AQ
09/27ETF Preview: ETFs, Futures Bounce Pre-Bell After Recession Fears Prompted Se..
MT
09/27Merck & Co. Unit Buys Minority Stake In LeeO Precision Farming
MT
09/27Merck Says Keytruda Obtains Four New Approvals in Japan
MT
09/27Merck Animal Health Completes Minority Investment in LeeO Precision Farming
BU
09/27Merck's KEYTRUDA« (pembrolizumab) Receives Four New Approvals in Japan, Including in Hi..
BU
09/27AstraZeneca-Merck's Rare Genetic Condition Medicine Gets Approval in Japan
MT
09/26TILT Biotherapeutics Ltd Collaborates with Merck & Co., Inc on Immunotherapy Clinical T..
CI
More news
News in other languages on MERCK & CO., INC.
09/27Keytruda de Merck & Co. obtient quatre nouvelles approbations au Japon pour des indicat..
09/27La division Merck de Merck Animal Health conclut un investissement minoritaire dans Lee..
09/27Merck : quatre nouvelles approbations pour Keytruda au Japon
09/27Aperçu des ETF : Les ETF et les contrats à terme rebondissent avant la cl..
09/27Une unité de Merck & Co. achète une participation minoritaire dans LeeO Precision Farmi..
09/27Merck déclare que Keytruda a obtenu quatre nouvelles approbations au Japon
09/26ANALYSEN DES TAGES von Dow Jones Newswires (26.09.2022)
09/26TILT Biotherapeutics Ltd collabore avec Merck & Co., Inc sur un essai clinique d'immuno..
09/23Merck : remporte la 1ère bataille judiciaire pour ses brevets
09/22Les actions américaines terminent en baisse jeudi malgré des gains dans le secteur de l..
More news
Analyst Recommendations on MERCK & CO., INC.
09/14Merck & Co. Rises After Berenberg Upgrade
MT
09/14Berenberg Bank Upgrades Merck to Buy From Hold, Adjusts Price Target to $100 From $95
MT
09/12SVB Securities LLC Raises Merck & Company's Price Target to $109 From $105, Keeps Outpe..
MT
08/16Seagen Upgraded by RBC to Outperform From Sector Perform, Price Target Raised to $188 F..
MT
08/01UBS Adjusts Merck & Company Price Target to $97 From $98, Maintains Neutral Rating
MT
More recommendations
Press releases
09/27TILT Biotherapeutics Collaborates with MSD on Immunotherapy Clinical Trial in Checkpoin..
AQ
09/27Merck Animal Health Completes Minority Investment in LeeO Precision Farming
BU
09/27Merck's KEYTRUDA« (pembrolizumab) Receives Four New Approvals in Japan, Including in Hi..
BU
09/23Merck - LYNPARZA Approved in China as First-Line Maintenance Treatment with Bevacizumab..
AQ
09/22Merck Animal Health to Acquire Vence
BU
More press releases
Upcoming event on MERCK & CO., INC.